Sees 2024 revenue $4.0B-$4.2B, consensus $4.1B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JAZZ:
- Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
- JAZZ Earnings this Week: How Will it Perform?
- Jazz completes rolling submission of BLA for zanidatamab antibody
- Jazz Pharmaceuticals price target raised to $188 from $171 at Piper Sandler
- Jazz Pharmaceuticals price target raised to $230 from $225 at Stifel